BHCBausch Health Companies Inc
Earnings Recap
• Reported GAAP EPS of -$3.82 down -2287.50% YoY • Reported revenue of $1.82B down -19.64% YoY • Bausch Health reaffirmed its full-year 2026 guidance for Revenue, Adjusted EBITDA (non-GAAP), and Adjusted Cash Flow from Operations (non-GAAP), indicating a maintained outlook for the company's financial performance.
Bullish
Bausch Health achieved 12% consolidated revenue growth to $2.52 billion and 27% Adjusted EBITDA growth to $837 million. The company delivered its twelfth consecutive quarter of revenue and Adjusted EBITDA growth, notably in Solta Medical and Salix segments.
Bearish
Bausch Health reported a significant GAAP Net Loss of $1,423 million due to a $1,426 million goodwill impairment charge. The Diversified segment revenues decreased 10%, and International organic revenue was flat due to LOE.